Mangoceuticals announces upcoming launch of its sildenafil based Mango ED

Mangoceuticals announces the upcoming release of its second Mango ED product leveraging the Company’s existing custom compound alongside Sildenafil, which is the active ingredient found in Viagra. The launch of the Company’s Sildenafil based Mango ED product is scheduled to be available for purchase online this summer. “Our intent with the launch of this new product is to establish Mango as a legitimate competitor armed with the biotechnology behind Tadalafil and Sildenafil, both of which are the two runaway winners in the ED space over the past two decades,” noted Jacob Cohen, CEO and Co-Founder of MangoRx. “The ED market has already proven to be big enough to accommodate multiple competing products. Some people like Pepsi and others prefer Coca-Cola. Tadalafil and Sildenafil are both effective biotech solutions and we believed it was important to make both options available in order to capture additional market share and not exclude potential customers based on personal preferences.”